BACKGROUND: The majority of interventions for knee osteoarthritis aim to reduce knee pain with the assumption that improvements in function will automatically follow. However, this assumption is not universally true, and a paradoxical decline in function is not uncommon following reduction in knee pain. OBJECTIVE: The purpose of this study was to examine what factors beyond knee pain are important for functional decline among people with reductions in knee pain. DESIGN: This was an observational cohort study. METHODS: The Multicenter Osteoarthritis Study (MOST) is a National Institutes of Health-funded longitudinal study of people who have or are at high risk for knee osteoarthritis. This study included individuals who had a meaningful reduction in pain in either knee over 30 months, defined as a 41% decrease in visual analog scale pain score with an absolute decrease of ≥20/100. Meaningful decline in walking speed was defined as a decrease of 0.1 m/s during a 20-m walk. To examine the association of risk factors with meaningful decline in walking speed, risk ratios were calculated and adjusted for potential confounders. RESULTS: Of the 465 people with a meaningful reduction in knee pain (mean [SD] age=63.3 [7.8] years, 67% female, 82% Caucasian, mean [SD] body mass index=31.3 [6.3] kg/m(2)), 20% had a meaningful decline in walking speed. Adjusting for confounders, participants with new comorbidity and those with widespread pain had 1.8 and 1.7 times the risk of decline compared with their counterparts with no comorbidity or widespread pain (adjusted risk ratio=1.8 [95% confidence interval=1.1-3.0] and 1.7 [95% confidence interval=1.1-2.8], respectively). LIMITATIONS: Generalizability is limited to people with a reduction in knee pain. CONCLUSIONS: Reductions in knee pain are not always accompanied by improvements in walking speed. Health providers should consider that the onset of new comorbidity and presence of widespread pain may increase the risk of functional decline despite a reduction in knee pain.
BACKGROUND: The majority of interventions for knee osteoarthritis aim to reduce knee pain with the assumption that improvements in function will automatically follow. However, this assumption is not universally true, and a paradoxical decline in function is not uncommon following reduction in knee pain. OBJECTIVE: The purpose of this study was to examine what factors beyond knee pain are important for functional decline among people with reductions in knee pain. DESIGN: This was an observational cohort study. METHODS: The Multicenter Osteoarthritis Study (MOST) is a National Institutes of Health-funded longitudinal study of people who have or are at high risk for knee osteoarthritis. This study included individuals who had a meaningful reduction in pain in either knee over 30 months, defined as a 41% decrease in visual analog scale pain score with an absolute decrease of ≥20/100. Meaningful decline in walking speed was defined as a decrease of 0.1 m/s during a 20-m walk. To examine the association of risk factors with meaningful decline in walking speed, risk ratios were calculated and adjusted for potential confounders. RESULTS: Of the 465 people with a meaningful reduction in knee pain (mean [SD] age=63.3 [7.8] years, 67% female, 82% Caucasian, mean [SD] body mass index=31.3 [6.3] kg/m(2)), 20% had a meaningful decline in walking speed. Adjusting for confounders, participants with new comorbidity and those with widespread pain had 1.8 and 1.7 times the risk of decline compared with their counterparts with no comorbidity or widespread pain (adjusted risk ratio=1.8 [95% confidence interval=1.1-3.0] and 1.7 [95% confidence interval=1.1-2.8], respectively). LIMITATIONS: Generalizability is limited to people with a reduction in knee pain. CONCLUSIONS: Reductions in knee pain are not always accompanied by improvements in walking speed. Health providers should consider that the onset of new comorbidity and presence of widespread pain may increase the risk of functional decline despite a reduction in knee pain.
Authors: K M Jordan; N K Arden; M Doherty; B Bannwarth; J W J Bijlsma; P Dieppe; K Gunther; H Hauselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; B Leeb; M Lequesne; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; U Serni; B Swoboda; G Verbruggen; I Zimmerman-Gorska; M Dougados Journal: Ann Rheum Dis Date: 2003-12 Impact factor: 19.103
Authors: S G Leveille; S Ling; M C Hochberg; H E Resnick; K J Bandeen-Roche; A Won; J M Guralnik Journal: Ann Intern Med Date: 2001-12-18 Impact factor: 25.391
Authors: Stephanie Studenski; Subashan Perera; Dennis Wallace; Julie M Chandler; Pamela W Duncan; Earl Rooney; Michael Fox; Jack M Guralnik Journal: J Am Geriatr Soc Date: 2003-03 Impact factor: 5.562
Authors: Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson Journal: Arthritis Rheum Date: 2004-05
Authors: D T Felson; R C Lawrence; P A Dieppe; R Hirsch; C G Helmick; J M Jordan; R S Kington; N E Lane; M C Nevitt; Y Zhang; M Sowers; T McAlindon; T D Spector; A R Poole; S Z Yanovski; G Ateshian; L Sharma; J A Buckwalter; K D Brandt; J F Fries Journal: Ann Intern Med Date: 2000-10-17 Impact factor: 25.391
Authors: Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor Journal: Ageing Res Rev Date: 2015-10-14 Impact factor: 10.895
Authors: Devyani Misra; David T Felson; Rebecca A Silliman; Michael Nevitt; Cora E Lewis; James Torner; Tuhina Neogi Journal: J Gerontol A Biol Sci Med Sci Date: 2014-07-25 Impact factor: 6.053
Authors: U-S D T Nguyen; D T Felson; J Niu; D K White; N A Segal; C E Lewis; M Rasmussen; M C Nevitt Journal: Osteoarthritis Cartilage Date: 2014-02-06 Impact factor: 6.576
Authors: Jasmijn F M Holla; Diana C Sanchez-Ramirez; Marike van der Leeden; Johannes C F Ket; Leo D Roorda; Willem F Lems; Martijn P M Steultjens; Joost Dekker Journal: J Behav Med Date: 2014-05-20
Authors: Lisa C Carlesso; Jingbo Niu; Neil A Segal; Laura A Frey-Law; Cora E Lewis; Michael C Nevitt; Tuhina Neogi Journal: J Rheumatol Date: 2017-03-01 Impact factor: 4.666
Authors: Hamid Abbasi-Bafghi; Hamid R Fallah-Yakhdani; Onno G Meijer; Henrica C W de Vet; Sjoerd M Bruijn; Li-Yong Yang; Dirk L Knol; Barend J Van Royen; Jaap H van Dieën Journal: BMC Musculoskelet Disord Date: 2012-05-06 Impact factor: 2.362